Literature DB >> 19273255

Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers.

Catarina Castro Alves1, Fatima Carneiro, Heinz Hoefler, Karl-Friedrich Becker.   

Abstract

Epithelial-mesenchymal-transition (EMT) is a crucial process during morphogenesis of multi-cellular organisms. EMT not only is a normal developmental process but also plays a role in tumor invasion and metastasis. Indeed, molecules involved in EMT, such as the transcription factor and E-cadherin repressor Slug (SNAI2), have recently been demonstrated to be important for cancer cells to down-regulate epithelial markers and up-regulate mesenchymal markers in order to become motile and invasive. Here we summarize major studies focusing on Slug expression in human tumor samples. We review a total of 13 studies involving 1150 cases from 9 different types of tumors. It is becoming clear that this transcription factor plays a role in the progression of some tumor types, including breast and gastric cancer. Interestingly, Slug expression is not always associated with down-regulation of E-cadherin. The mode of action, the signaling pathways involved in its regulation, and the interplay with other EMT regulators need to be addressed in future studies in order to fully understand Slug's role in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273255     DOI: 10.2741/3433

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  109 in total

1.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

Review 2.  Role of MTA2 in human cancer.

Authors:  Kyle R Covington; Suzanne A W Fuqua
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

3.  Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.

Authors:  Yasuto Uchikado; Hiroshi Okumura; Sumiya Ishigami; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Yoshiaki Kita; Shoji Natsugoe
Journal:  Gastric Cancer       Date:  2011-01-28       Impact factor: 7.370

Review 4.  The skinny on Slug.

Authors:  Stephanie H Shirley; Laurie G Hudson; Jing He; Donna F Kusewitt
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

5.  Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines.

Authors:  Modjtaba Emadi Baygi; Zahra-Soheila Soheili; Frank Essmann; Abdolkhaleg Deezagi; Rainer Engers; Wolfgang Goering; Wolfgang A Schulz
Journal:  Tumour Biol       Date:  2010-05-27

Review 6.  Invasion and metastasis of renal cell carcinoma.

Authors:  Shuji Mikami; Mototsugu Oya; Ryuichi Mizuno; Takeo Kosaka; Ken-ichi Katsube; Yasunori Okada
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

Review 7.  SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Authors:  Sarah Phillips; Charlotte Kuperwasser
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

8.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Authors:  Myriem Boufraqech; Naris Nilubol; Lisa Zhang; Sudheer Kumar Gara; Samira M Sadowski; Amit Mehta; Mei He; Sean Davis; Jennifer Dreiling; John A Copland; Robert C Smallridge; Martha M Quezado; Electron Kebebew
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

9.  RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin.

Authors:  M H Hwang; K H Cho; K J Jeong; Y-Y Park; J M Kim; S-L Yu; C G Park; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

10.  Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Authors:  Michael A Augello; Craig J Burd; Ruth Birbe; Christopher McNair; Adam Ertel; Michael S Magee; Daniel E Frigo; Kari Wilder-Romans; Mark Shilkrut; Sumin Han; Danielle L Jernigan; Jeffry L Dean; Alessandro Fatatis; Donald P McDonnell; Tapio Visakorpi; Felix Y Feng; Karen E Knudsen
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.